COMPASS 2-HS – Adult’s Hidradenitis Suppurativa Study (40 Weeks)

For condition: Hidradenitis Suppurativa

COMPASS 2-HS – Adult’s Hidradenitis Suppurativa Study (40 Weeks)

Study Summary

Who Can Participate?
Males or females aged ≥18 to ≤75 years with moderate to severe hidradenitis suppurativa (HS) may participate.

Inclusion Criteria
• have a diagnosis of HS based on clinical history and physical examination for at least ≥1 year
• have HS lesions present in at least 2 distinct anatomic areas
• have HS defined as a total of ≥5 inflammatory lesions (ie, number of abscesses plus number of inflammatory nodules)
• have either had an inadequate response, had intolerance, or had recurrence after ≥3 months systemic antibiotic for treatment of HS

Participant Information
• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialise in treating HS (up to 22 visits)
• Will receive an investigative subcutaneous treatment (study drug) and a placebo
• Reimbursement for study-related expenses may be provided

Click here to Register

For more information about this trial, please visit ClinicalTrials.gov

Ready to Find a Trial?

Start your journey here.
Find a Trial

Can’t Find a Trial Near You?

Complete a general registration to let us know who you are and what you’re interested in. We can keep your information on file and contact you when there is a trial that may be suitable for you.
General Registration

Privacy Policy

Last Revised: July 2024

I agree to the Privacy PolicyI do not agree

Registration

Enrolling:

Clinic:

Doctor:

Please fill in your contact details:

Find a Trial